Paolo Tarantino (@ptarantinomd) 's Twitter Profile
Paolo Tarantino

@ptarantinomd

MD, PhD, Medical Oncologist | Clinical Fellow @DanaFarber | @Harvard. SoMe Editor @ESMO_Open. Interested in breast oncology, HER2, ADCs and good music.

ID: 958742483856486400

calendar_today31-01-2018 16:43:15

13,13K Tweet

26,26K Takipçi

651 Takip Edilen

Paolo Tarantino (@ptarantinomd) 's Twitter Profile Photo
Paolo Tarantino
@ptarantinomd

8 days ago

Interesting results from a 1L trial of ET+ribo+ trastuzumab for HR+/HER2+ MBC (n=90). ORR 61%, mPFS 30 months. Confirming what we’re realizing more and more: patients with triple-positive metastatic disease NEED to receive a CDK4/6 inhibitor at part of their 1L treatment. #ASCO25

Interesting results from a 1L trial of ET+ribo+ trastuzumab for HR+/HER2+ MBC (n=90). ORR 61%, mPFS 30 months. Confirming what we’re realizing more and more: patients with triple-positive metastatic disease NEED to receive a CDK4/6 inhibitor at part of their 1L treatment. #ASCO25